MUC1 and neoplasm: Using immunohistochemistry, the present PSC case was confirmed with the positive staining of epithelial markers (CK and EMA) and a mesenchymal marker (Vimentin), while Ki67 positivity confirmed the aggressiveness of PSC in tumor cell proliferation.